Ozone-induced release of neuropeptides from human nasal mucosa cells

International Archives of Allergy and Immunology

Volumn 129, Issue 2, 2002, Pages 145-151

  Schierhorn, Katrin ^b   Hanf, Gerald ^b   Fischer, Axel ^b   Umland, Beate ^b   Olze, Heidi ^b   Kunkel, Gert ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NONE

Author keywords

Mucosal inflammation; Neural mechanisms; Neurokinin A; Sensory nerves; Substance P

Indexed keywords

NEUROKININ A; NEUROPEPTIDE; SUBSTANCE P;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MUCOSA CELL; NOSE ALLERGY; NOSE MUCOSA; NOSE OBSTRUCTION; PRIORITY JOURNAL; SAMPLING; SENSORY NERVE; TISSUE CULTURE; UPPER RESPIRATORY TRACT;

BIOPSY; CULTURE TECHNIQUES; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; NASAL MUCOSA; NEUROKININ A; OZONE; RHINITIS, ALLERGIC, PERENNIAL; STATISTICS, NONPARAMETRIC; SUBSTANCE P;

EID: 0036977111     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065879     Document Type: Article

References (59)

1. Hazucha MJ: Relationship between ozone exposure and pulmonary function changes. J Appl Physiol 1987;62:1671-1680.
2. Kreit JW, Gross KB, Moore TB, Lorenzen TJ, D'Arcy J, Eschenbacher WL: Ozone-induced changes in pulmonary function and bronchial hyperresponsiveness in asthmatics. J Appl Physiol 1989;66:217-222.
3. Kunkel G, Schierhorn K: Air pollution and allergic and non-allergic airway disease. Allergy Clin Immunol Int 1999;26:82-85.
4. Peden DB: Mechanisms of pollution-induced airway disease: In vivo studies. Allergy 1997;52:37-44.
5. Aris RM, Christian D, Hearne PQ, Kerr K, Finkbeiner WE, Balmes JR: Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis 1993;148:1363-1372.
6. Devlin RB, McDonnell WF, Mann R, Becker S, House DE, Schreinemachers D, Koren HS: Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol 1991;4:72-81.
7. Koren HS, Devlin RB, Graham DE, Mann R, McGee MP, Horstman DH, Kozumbo WJ, Becker S, House DE, McDonnell WF, Bromberg PA: Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 1989;139:407-415.
8. Koren HS, Hatch GE, Graham DE: Nasal lavage as a tool in assessing acute inflammation in response to inhaled pollutants. Toxicology 1990;60:15-25.
9. Schelegle ES, Siefkin AD, McDonald RJ: Time course of ozone-induced neutrophilia in normal humans. Am Rev Respir Dis 1991;143:1353-1358.
10. Koren HS, Devlin RB, Becker S, Perez R, McDonnell WF: Time-dependent changes of markers associated with inflammation in the lungs of humans exposed to ambient levels of ozone. Toxicol Pathol 1991;19:406-411.
11. 1 and FVC do not correlate with measures of inflammation. Am J Respir Crit Care Med 1996;153:904-909.
12. Blomberg A, Mudway IS, Nordenhall C, Hedenstrom H, Kelly FJ, Frew AJ, Holgate ST, Sandstrom T: Ozone-induced lung function decrements do not correlate with early airway inflammatory or antioxidant responses. Eur Respir J 1999;14:1418-1428.
13. Beckett WS, McDonnell WF, Horstman DH, House DE: Role of the parasympathetic nervous system in acute lung response to ozone. J Appl Physiol 1985;59:1879-1885.
14. Folinsbee LJ: Human health effects of air pollution. Environ Health Perspect 1993;100:45-56.
15. Nishiyama H, Ikeda H, Kaneko T, Fu L, Kudo M, Ito T, Okubo T: Neuropeptides mediate the ozone-induced increase in the permeability of the tracheal mucosa in guinea pigs. Am J Physiol 1998;275:L231-L238.
16. Passannante A, Hazucha MJ, Bromberg PA, Seal E, Folinsbee L, Koch G: Nociceptive mechanisms modulate ozone-induced human lung function decrements. J Appl Physiol 1998;85:1863-1870.
17. Takebayashi T, Abraham J, Murthy GG, Lilly C, Rodger I, Shore SA: Role of tachykinins in airway responses to ozone in rats. J Appl Physiol 1998;85:442-450.
18. Vesely KR, Hyde DM, Stovall MY, Harkema JR, Green JF, Schelegle ES: Capsaicin-sensitive C-fiber-mediated protective responses in ozone inhalation in rats. J Appl Physiol 1999;86:951-962.
19. Heaney LG, Cross LJ, McGarvey LP, Buchanan KD, Ennis M, Shaw C: Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects. Thorax 1998;53:357-362.
20. Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G: Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol 1992;90:646-652.
21. 2a in the airways of human subjects. Am J Respir Cell Mol Biol 1993;9:568-572.
22. Krishna M, Springall D, Meng QH: Effects of 0.2 ppm ozone on the sensory nerves in the bronchial mucosa of healthy humans. Am J Respir Crit Care Med 1996;153:A700.
23. Krishna MT, Chauhan AJ, Frew AJ, Holgate ST: Toxicological mechanisms underlying oxidant pollutant-induced airway injury. Rev Environ Health 1998;14:59-71.
24. Krishna MT, Springall D, Meng QH, Withers N, Macleod D, Biscione G, Frew A, Polak J, Holgate ST: Effects of ozone on epithelium and sensory nerves in the bronchial mucosa of healthy humans. Am J Respir Crit Care Med 1997;156:943-950.
25. Baraniuk JN: Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa. J Allergy Clin Immunol 1992;90:1045-1050.
26. Joos GF, Germonpre PR, Pauwels RA: Role of tachykinins in asthma. Allergy 2000;55:321-337.
27. Schierhorn K, Brunnée T, Paus R, Schultz KD, Niehus J, Agha-Mir-Salim P, Kunkel G: Gelatin sponge-supported histoculture of human nasal mucosa. In Vitro Cell Dev Biol Anim 1995;31:215-220.
28. Hanf G, Schierhorn K, Brunnée T, Noga O, Verges D, Kunkel G: Substance P induced histamine release from nasal mucosa of subjects with and without allergic rhinitis. Inflamm Res 2000;49:520-523.
29. Schierhorn K, Brunnée T, Schultz KD, Jahnke V, Kunkel G: Substance P-induced histamine release from human nasal mucosa in vitro. Int Arch Allergy Immunol 1995b;107:109-114.
30. Schierhorn K, Zhang M, Kacy M, Kunkel G: Ozone-induced augmentation of eicosanoid metabolism in human nasal mucosa in vitro. Int Arch Allergy Immunol 1997;113:312-315.
31. Schierhorn K, Zhang M, Matthias C, Kunkel G: Influence of ozone and nitrogen dioxide on histamine and interleukin formation in a human nasal mucosa system. Am J Respir Cell Mol Biol 1999;20:1013-1019.
32. Schierhorn K, Zhang M, Matthias C, Kunkel G: Ozone-induced release of histamine in human nasal mucosa of smokers and nonsmokers in organ culture. Int Arch Allergy Immunol 1999;118:333-334.
33. Tasman AJ, Bogatzki B, Heppt W, Hauser-Kronberger C, Fischer A: Nitric oxide synthase in the innervation of the human nasal mucosa: Correlation with neuropeptides and tyrosine hydroxylase. Laryngoscope 1998;108:128-133.
34. Canning BJ, Fischer A: Localization of cholinergic nerves in lower airways of guinea pigs using antisera to choline acetyltransferase. Am J Physiol 1997;272:L731-L738.
35. Leikauf GD, Hamilton R, Holian A, Eschenbacher WL: Ozone induced augmentation of eicosanoid metabolism in epithelial cells from bovine trachea. Am Rev Respir Dis 1988;137:435-442.
36. 3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 1986;60:1321-1326.
37. Eschenbacher WL, Ying RL, Kreit JW, Gross KB: Ozone induced lung function changes in normal and asthmatic subjects and the effect of indomethacin; in Schneider T, Lee SD, Wolters GJR, Grant LD (eds): Atmospheric Ozone Research and Its Policy Implications. Nijmegen, Elsevier, 1989, pp 493-499.
38. Hazucha MJ, Madden MC, Pape C, Becker S, Devlin R, Koren HS, Kehrl H, Bromberg PA: Effects of cyclooxygenase inhibition on ozone-induced respiratory inflammation and lung function changes. Eur J Appl Physiol 1996;73:17-27.
39. Schelegle ES, Adams WC, Siefkin AD: Indomethacin pretreatment reduces ozone-induced pulmonary function decrements in human subjects. Am Rev Respir Dis 1987;136:1350-1354.
40. Ying RL, Gross KB, Teizo TS, Eschenbacher WL: Indomethacin does not inhibit the ozone-induced increase in bronchial responsiveness in human subjects. Am Rev Respir Dis 1990;142:817-821.
41. Hazucha MJ, Bates DV, Bromberg PA: Mechanism of action of ozone on the human lung. J Appl Physiol 1989;67:1535-1541.
42. Barnes PJ, Baraniuk JN, Belvisi MG: Neuropeptides in the respiratory tract. Part I. Am Rev Respir Dis 1991;144:1187-1198.
43. Barnes PJ, Baraniuk JN, Belvisi MG: Neuropeptides in the respiratory tract. Part II. Am Rev Respir Dis 1991;144:1391-1399.
44. Fewtrell CM, Foreman JC, Jordan CC, Oehme P, Renner H, Stewart JM: The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol 1982;330:393-411.
45. Perianin A, Snyderman R, Malfroy B: Substance P primes human neutrophil activation: A mechanism for neurological regulation of inflammation. Biochem Biophys Res Commun 1989;161:520-524.
46. 2+ concentration and inositol phosphate formation. J Immunol 1988;141:2118-2124.
47. Shanahan F, Denburg JA, Fox J, Bienenstock J, Befus D: Mast cell heterogeneity: Effects of neuroenteric peptides on histamine release. J Immunol 1985;135:1331-1337.
48. Stanisz AM, Befus D, Bienenstock J: Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 1986;136:152-156.
49. de Giorio R, Tazzari PL, Barbara G, Stanghellini V, Corinaldesi R: Detection of substance P immunoreactivity in human peripheral leukocytes. J Neuroimmunol 1998;82:175-181.
50. Germonpré PR, Bullock GR, Lambrecht BN, van de Velde V, Luyten WH, Joos GF, Pauwels RA: Presence of substance P and neurokinin 1 receptors in human sputum macrophages and U-937 cells. Eur Respir J 1999;14:776-782.
51. Ho WZ, Lai JP, Zhu XH, Uvaydova M, Douglas SD: Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 1997;159:5654-5660.
52. Kaltreider HB, Ichikawa S, Byrd PK, Ingram DA, Kishiyama JL, Sreedharan SP, Warnock ML, Beck JM, Goetzl EJ: Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am J Respir Cell Mol Biol 1997;16:133-144.
53. Killingsworth CR, Shore SA, Alessandrini F, Dey RD, Paulauskis JD: Rat alveolar macrophages express preprotachykinin gene-I mRNA-encoding tachykinins. Am J Physiol 1997;273:L1073-L1081.
54. Lai JP, Douglas SD, Ho WZ: Human lymphocytes express substance P and its receptor. J Neuroimmunol 1998;86:80-86.
55. Lai JP, Douglas ST, Rappaport E, Wu JM, Ho WZ: Identification of a delta isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes. J Neuroimmunol 1998;91:121-128.
56. Lambrecht BN, Germonpré PR, Everaert EG, Carro-Muino I, de Veerman M, de Felipe C, Hunt SP, Thielemans K, Joos GF, Pauwels RA: Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol 1999;29:3815-3825.
57. Metwali A, Blum AM, Ferraris L, Klein JS, Fiocchi C, Weinstock JV: Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. J Neuroimmunol 1994;52:69-78.
58. Weinstock JL, Blum A, Walder J, Walder R: Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. J Immunol 1988;141:961-966.
59. Weinstock JV, Blum AM: Tachykinin production in granulomas of murine schistosomiasis mansoni. J Immunol 1989;142:3256-3261.